Skip to content

Glycerol Substrate

by Simmler & Son, Inc.

510(k) K771905

Glycerol Substrate is a medical device (FDA Class I; FDA product code CDT, Lipase Hydrolysis/Glycerol Kinase Enzyme, Triglycerides) made by Simmler & Son, Inc., cleared under FDA 510(k) K771905 on 6 Dec 1977, active as of 22 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK771905 Date6 Dec 1977ClearedStatusActive

Official records

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
CDT
Device class
Class I
Regulation
21 CFR Part 862.1705
Advisory committee
Clinical Chemistry
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code CDT (Lipase Hydrolysis/Glycerol Kinase Enzyme, Triglycerides).

Other devices from Simmler & Son, Inc.

See all devices from Simmler & Son, Inc. →